Neoplasms, Glandular and Epithelial
Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.
Subtype terms (10)
More specific conditions that are subtypes of Neoplasms, Glandular and Epithelial in the MeSH hierarchy.
- Adenoma
39 drugs (33 approved, 6 experimental)
- Carcinoma
358 drugs (168 approved, 190 experimental)
- Neoplasms, Adnexal and Skin Appendage
12 drugs (9 approved, 3 experimental)
- Neoplasms, Basal Cell
13 drugs (11 approved, 2 experimental)
- Neoplasms, Cystic, Mucinous, and Serous
2 drugs approved
- Neoplasms, Ductal, Lobular, and Medullary
- Neoplasms, Fibroepithelial
- Neoplasms, Mesothelial
4 drugs approved
- Neoplasms, Neuroepithelial
27 drugs (21 approved, 6 experimental)
- Neoplasms, Squamous Cell
37 drugs (23 approved, 14 experimental)
Drugs by status
Phase 3 trials (6)
- sorafenib
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- abt-869
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
Phase 2 trials (18)
Phase 1 trials (5)
Other trials (2)
Organizations
Organization Involved with Phase 2 Indications (19)
- Bristol-Myers Squibb
- Catalysis SL
- Karyopharm Therapeutics Inc
- Huazhong University of Science and Technology
- Cedars-Sinai Medical Center
- Georgetown University
- GSO Global Clinical Research BV
- Johns Hopkins University
- Nanjing Medical University
- New York University
- Rutgers University
- Fudan University
- Tel Aviv University
- University of Copenhagen
- Curie Institute
- Institut Gustave Roussy
- University of Lyon
- Sungkyunkwan University
- Jiangsu Cancer Institute & Hospital
Organization Involved with Phase 1 Indications (14)
- Genentech
- Blueprint Medicines Corporation
- INC Research
- PsiOxus Therapeutics Ltd
- Syndax Pharmaceuticals
- National Cancer Institute (NCI)
- Providence Health & Services
- Sun Yat-Sen University
- University of Texas at Houston
- University of Alabama, Birmingham
- Viventia Biotech Inc.
- Washington University in St. Louis
- Baili Pharmaceutical Group
- SystImmune Inc.
Organization Involved with Other Experimental Indications (3)